2024-518150-17-00CompletedPhase 1
Not applicable
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Mar 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 27 Nov 2024
- Start date
- 10 Mar 2025
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Diseases
- Cystic fibrosis
- EU CT number
- 2024-518150-17-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 40
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.